Which hedge funds own PALI? PALISADE BIO INC, Q2 2026 13F holders
42 tracked hedge funds disclosed a position in PALI (PALISADE BIO INC) in their Q2 2026 13F filings, worth $208.0m in total. The largest holder by portfolio weight is B Group, Inc. at 13.5% of its book. 6 opened a new position this quarter: Ally Bridge Group (NY) LLC, Soleus Capital Management, L.P., Verdad Advisers, LP, Quinn Opportunity Partners LLC. 11 exited: Commodore Capital LP, Exome Asset Management LLC, CTC Alternative Strategies, Ltd..
- 42
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 6
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 11
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $30.2m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $15.1m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $208m
- Combined value Sum of the holders' reported positions in the security.
- 3.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Commodore Capital LP | 0.7% | $12.6m |
| Exome Asset Management LLC | 0.6% | $1.1m |
| CTC Alternative Strategies, Ltd. | 0.07% | $30.5k |
| Diametric Capital, LP | 0.02% | $90.8k |
| Prelude Capital Management, LLC | 0.02% | $233k |
| Catalyst Funds Management Pty Ltd | 0.01% | $55.0k |
| Graham Capital Management, L.P. | 0.01% | $185k |
| Brevan Howard Capital Management LP | 0.0% | $376k |
| Hudson Bay Capital Management LP | 0.0% | $156k |
| Schonfeld Strategic Advisors LLC | 0.0% | $58.0k |
| Qube Research & Technologies Ltd | 0.0% | $261k |
Ownership over time
Who discovered PALI first? Beta
The run: Q2 2025 → Q4 2025, +246%
| B Group, Inc. high conviction | Q4 2025 | – | +0.9 pts |
| Great Point Partners LLC | Q1 2026 | – | +0.3 pts |
| Propel Bio Management, LLC | Q2 2026 | – | +0.2 pts |
| Octagon Capital Advisors LP | Q4 2025 | – | −0.3 pts |
| Boxer Capital Management, LLC | Q4 2025 | – | −0.4 pts |
| Commodore Capital LP | Q4 2025 | – | −0.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.